U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Unresectable Ovarian Serous Adenocarcinoma

MedGen UID:
1695995
•Concept ID:
C5205548
•
Neoplastic Process

Definition

Ovarian serous adenocarcinoma that is not amenable to surgical resection. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVUnresectable Ovarian Serous Adenocarcinoma

Professional guidelines

PubMed

Long-term Benefit of Tumor Volume-Directed Involved Field Radiation Therapy in the Management of Recurrent Ovarian Cancer.
Albuquerque K, Patel M, Liotta M, Harkenrider M, Guo R, Small W Jr, Ronald P
Int J Gynecol Cancer 2016 May;26(4):655-60. doi: 10.1097/IGC.0000000000000653. PMID: 26825832

Recent clinical studies

Etiology

Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study.
Lim H, Bang SH, Kim Y, Cho SH, Shin W, Kim SI, Kim TH, Suh DH, Lim MC, Kim JW
BMC Cancer 2022 Jun 27;22(1):703. doi: 10.1186/s12885-022-09746-3. PMID: 35761211Free PMC Article
Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
da Costa Miranda V, de Souza Fêde ÂB, Dos Anjos CH, da Silva JR, Sanchez FB, da Silva Bessa LR, de Paula Carvalho J, Filho EA, de Freitas D, Del Pilar Estevez Diz M
Gynecol Oncol 2014 Feb;132(2):287-91. Epub 2013 Dec 9 doi: 10.1016/j.ygyno.2013.12.002. PMID: 24333355
Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK, Balzer BL, Longacre TA
Am J Surg Pathol 2006 Oct;30(10):1209-21. doi: 10.1097/01.pas.0000213299.11649.fa. PMID: 17001150
Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up.
Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR
Am J Surg Pathol 2005 Jun;29(6):707-23. doi: 10.1097/01.pas.0000164030.82810.db. PMID: 15897738
Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study.
Morice P, Brehier-Ollive D, Rey A, Atallah D, Lhommé C, Pautier P, Pomel C, Camatte S, Duvillard P, Castaigne D
Ann Oncol 2003 Jan;14(1):74-7. doi: 10.1093/annonc/mdg003. PMID: 12488296

Diagnosis

Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma.
Shin K, Kim KH, Yoon MS, Suh DS, Lee JY, Kim A, Eo W
Adv Clin Exp Med 2016 May-Jun;25(3):513-21. doi: 10.17219/acem/62540. PMID: 27629740
Long-term Benefit of Tumor Volume-Directed Involved Field Radiation Therapy in the Management of Recurrent Ovarian Cancer.
Albuquerque K, Patel M, Liotta M, Harkenrider M, Guo R, Small W Jr, Ronald P
Int J Gynecol Cancer 2016 May;26(4):655-60. doi: 10.1097/IGC.0000000000000653. PMID: 26825832
Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
da Costa Miranda V, de Souza Fêde ÂB, Dos Anjos CH, da Silva JR, Sanchez FB, da Silva Bessa LR, de Paula Carvalho J, Filho EA, de Freitas D, Del Pilar Estevez Diz M
Gynecol Oncol 2014 Feb;132(2):287-91. Epub 2013 Dec 9 doi: 10.1016/j.ygyno.2013.12.002. PMID: 24333355
Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK, Balzer BL, Longacre TA
Am J Surg Pathol 2006 Oct;30(10):1209-21. doi: 10.1097/01.pas.0000213299.11649.fa. PMID: 17001150
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY
Gynecol Oncol 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145. PMID: 10053096

Therapy

Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study.
Lim H, Bang SH, Kim Y, Cho SH, Shin W, Kim SI, Kim TH, Suh DH, Lim MC, Kim JW
BMC Cancer 2022 Jun 27;22(1):703. doi: 10.1186/s12885-022-09746-3. PMID: 35761211Free PMC Article
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies.
Petrillo M, Zannoni GF, Beltrame L, Martinelli E, DiFeo A, Paracchini L, Craparotta I, Mannarino L, Vizzielli G, Scambia G, D'Incalci M, Romualdi C, Marchini S
Ann Oncol 2016 Apr;27(4):625-34. Epub 2016 Jan 17 doi: 10.1093/annonc/mdw007. PMID: 26782955
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study.
Petrillo M, Paris I, Vizzielli G, Amadio G, Cosentino F, Salutari V, Scambia G, Fagotti A
Ann Surg Oncol 2015 Dec;22 Suppl 3:S952-8. Epub 2015 Jun 3 doi: 10.1245/s10434-015-4651-8. PMID: 26036187
Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
da Costa Miranda V, de Souza Fêde ÂB, Dos Anjos CH, da Silva JR, Sanchez FB, da Silva Bessa LR, de Paula Carvalho J, Filho EA, de Freitas D, Del Pilar Estevez Diz M
Gynecol Oncol 2014 Feb;132(2):287-91. Epub 2013 Dec 9 doi: 10.1016/j.ygyno.2013.12.002. PMID: 24333355
Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study.
Morice P, Brehier-Ollive D, Rey A, Atallah D, Lhommé C, Pautier P, Pomel C, Camatte S, Duvillard P, Castaigne D
Ann Oncol 2003 Jan;14(1):74-7. doi: 10.1093/annonc/mdg003. PMID: 12488296

Prognosis

Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study.
Lim H, Bang SH, Kim Y, Cho SH, Shin W, Kim SI, Kim TH, Suh DH, Lim MC, Kim JW
BMC Cancer 2022 Jun 27;22(1):703. doi: 10.1186/s12885-022-09746-3. PMID: 35761211Free PMC Article
Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma.
Shin K, Kim KH, Yoon MS, Suh DS, Lee JY, Kim A, Eo W
Adv Clin Exp Med 2016 May-Jun;25(3):513-21. doi: 10.17219/acem/62540. PMID: 27629740
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies.
Petrillo M, Zannoni GF, Beltrame L, Martinelli E, DiFeo A, Paracchini L, Craparotta I, Mannarino L, Vizzielli G, Scambia G, D'Incalci M, Romualdi C, Marchini S
Ann Oncol 2016 Apr;27(4):625-34. Epub 2016 Jan 17 doi: 10.1093/annonc/mdw007. PMID: 26782955
Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK, Balzer BL, Longacre TA
Am J Surg Pathol 2006 Oct;30(10):1209-21. doi: 10.1097/01.pas.0000213299.11649.fa. PMID: 17001150
Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up.
Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR
Am J Surg Pathol 2005 Jun;29(6):707-23. doi: 10.1097/01.pas.0000164030.82810.db. PMID: 15897738

Clinical prediction guides

Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma.
Shin K, Kim KH, Yoon MS, Suh DS, Lee JY, Kim A, Eo W
Adv Clin Exp Med 2016 May-Jun;25(3):513-21. doi: 10.17219/acem/62540. PMID: 27629740
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study.
Petrillo M, Paris I, Vizzielli G, Amadio G, Cosentino F, Salutari V, Scambia G, Fagotti A
Ann Surg Oncol 2015 Dec;22 Suppl 3:S952-8. Epub 2015 Jun 3 doi: 10.1245/s10434-015-4651-8. PMID: 26036187
Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
Favero G, Macerox N, Pfiffer T, Köhler C, da Costa Miranda V, Estevez Diz Mdel P, Fukushima JT, Baracat EC, Carvalho JP
Oncology 2015;89(3):159-66. Epub 2015 May 1 doi: 10.1159/000381462. PMID: 25968072
Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
da Costa Miranda V, de Souza Fêde ÂB, Dos Anjos CH, da Silva JR, Sanchez FB, da Silva Bessa LR, de Paula Carvalho J, Filho EA, de Freitas D, Del Pilar Estevez Diz M
Gynecol Oncol 2014 Feb;132(2):287-91. Epub 2013 Dec 9 doi: 10.1016/j.ygyno.2013.12.002. PMID: 24333355
Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up.
Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR
Am J Surg Pathol 2005 Jun;29(6):707-23. doi: 10.1097/01.pas.0000164030.82810.db. PMID: 15897738

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...